Jennifer Geremia,

MSPAS, PA-C

Jennifer Geremia,

MSPAS, PA-C
Physician Associate, Brigham and Women’s Hospital
and Teaching Hospital of Harvard Medical School

Jennifer Geremia,

MSPAS, PA-C
Physician Associate, Brigham and Women’s Hospital
and Teaching Hospital of Harvard Medical School
Jennifer Geremia, MSPAS, PA-C, is a practicing physician associate (PA) in outpatient gastroenterology (GI) and advanced endoscopy at Brigham and Women’s Hospital in Boston at Teaching Hospital of Harvard Medical School. With GI experience for 14 years, including providing community and tertiary care across the spectrum of GI disease states, Jennifer is committed to patient care. She obtained a master’s degree in physician assistant studies from Massachusetts College of Pharmacy and Health Sciences. She is part of the clinical faculty at Massachusetts College of Pharmacy and Health Sciences PA Program, adjunct professor with GI experience at the University of New England PA program, and the Massachusetts General Hospital School of Health Professions PA Program. Also, she is a conference faculty presenter for the Gastroenterology and Hepatology Advanced Practice Providers National Organization and an advanced practice provider contributor to the American Society for Gastrointestinal Endoscopy.

Jennifer's Shared Resources

NAFLD: Rising Global Health Issue Tied to Metabolic Dysfunction, Gut Microbiome, and Emerging Therapies

Non-alcoholic fatty liver disease (NAFLD) is characterized by ≥5% hepatic steatosis unrelated to alcohol or drug use, primarily driven by...
Jennifer Geremia,
CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

MASLD: A Growing Global Health Concern Driven by Obesity, Diabetes, and Cardiovascular Risks

The terms nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) have been replaced by metabolic-dysfunction-associated steatotic liver disease (MASLD)...
Jennifer Geremia,
CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

Understanding MASH: The Severe Stage of MASLD Linked to Inflammation and Liver Damage

Metabolic dysfunction-associated fatty liver disease (MASLD), previously known as NAFLD or MAFLD, is a liver condition associated with metabolic syndrome...
Jennifer Geremia,
CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

Patients Share Stories About Non-Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) is a liver condition unrelated to alcohol consumption but can progress to serious complications like...
Jennifer Geremia,
CURATED BY:
Jennifer Geremia,
MSPAS, PA-C
Cropped view of the sporty woman measuring waist with tape at bright kitchen. Weight loss and diet concept

Rezdiffra and Noncirrhotic Non-alcoholic Steatohepatitis

The first US Food and Drug Administration-approved medication to treat noncirrhotic non-alcoholic steatohepatitis, otherwise known as NASH, is Rezdiffra (resmetirom)....
Jennifer Geremia,
CURATED BY:
Jennifer Geremia,
MSPAS, PA-C
Cropped view of the sporty woman measuring waist with tape at bright kitchen. Weight loss and diet concept

New Clinical Practice Update on Nonalcoholic Fatty Liver Disease in Lean Individuals

The American Gastroenterological Association has issued a new clinical practice update focused on the diagnosis, staging, and management of nonalcoholic...
Jennifer Geremia,
CURATED BY:
Jennifer Geremia,
MSPAS, PA-C
Share